Multifunction Cardiogram™
The Multifunction Cardiogram™ (MCG) is a revolutionary new kind of non-invasive diagnostic tool for measuring the health of a patient’s heart and the impact of ischemia and other problems. The MCG™ provides a method to detect and measure myocardial ischemia with unprecedented accuracy in minutes. It is a resting, non-invasive, non-chemical/non-radiation test that can be performed at the point of care by trained technical staff. With the help of the MCG™, physicians are able to make much more rapid, objective, and accurate diagnoses of heart diseases.
Our Story
An intractable problem in heart disease diagnosis exists: The lack of an early detection bedside tool that can deliver an accurate, timely, lifesaving diagnosis without incurring high costs or using often risky and invasive procedures. Premier Heart’s Multifunction Cardiogram ™ (MCG) Technology provides a perfectly safe and highly effective “Digital Diagnosis as a Service” (i.e., DDxAAS) platform trained via deep machine learning and AI analysis methods to purposefully and comprehensively solve this problem.
Premier Heart, LLC has spent more than two decades to ensure that MCG™ delivers where other modalities have failed, building on the back of a carefully curated, empirical, and 100% evidence-based clinical database to classify and differentiate various heart diseases and filling in the critical knowledge/information gaps in the current diagnostic arena. MCG™’s unprecedented early disease pattern detection capabilities and high accuracy are beyond the reach of the conventional imaging tools, such as nuclear, echo stress, CT, and PET scan, requiring only 10 minutes of testing without the exposure to radiation, IV contrast, drugs, stress, or risks of injury or death. MCG™ is easily accessible, with real time reports available 24/7/365 on the web at a very affordable cost!
We take pride in the dedication of Premier Heart, the developer of this disruptive technology, to successfully build MCG™ Technology relying on scientific principles and insisting on adopting methods that are objective, replicable, and reproducible, using only verifiable input and output to generate transparent and clinically useful results. Their efforts to establish the validation process as trustworthy and transparent without any quid pro quo is a result of decades of hard work. In that time, they have built a database of over 2 million patients tested. Increasing numbers of physician early adopters have joined our journey and trust MCG™ Technology as a vital tool to save the lives of their patients!
Due to the inability of the current modalities to detect microvascular heart disease, the problem created by inaccurate cardiac diagnostic tools is even more acute for women, leading in part to more women suffering longer term from heart disease than men.
The MCG™ is the culmination of the efforts of two generations of dedicated scientists, mathematicians, engineers, and physicians. It uses rapid, automated, cloud-based, empirically derived digitized clinical databases to give doctors around the world the access to a startlingly accurate diagnostic system.
Overview
The MCG™ uses a systems approach to modeling the heart and then comparing these models to a demographically appropriate risk-stratified database of similar patients using 166 indices with that database to aid both in the diagnosis and in predicting patient needs and outcomes.
The MCG™ was created to solve an intractable problem in cardiology: the unacceptable inaccuracies of the EKG and other cardiac-related diagnostic tools and the need for more accurate tools. The inaccuracy of the present diagnostic tools affects both patients with cardiac issues as well as patients whose symptoms may appear to be cardiac-related but are not actually cardiac-derived. An EKG can detect approximately 1/3 of patients with severe coronary artery disease, leaving 2/3 of the patients in danger of dying from their undetected illness. Patients showing signs and symptoms of cardiac-related conditions are often catheterized and have angiograms performed. However, 62 percent of these patients actually have no significant atherosclerosis.
Dr. Bruce Feldman, M.D., Chief Medical Officer, ADIG
How it Works
Premier Heart’s MCG™ System represents a radical departure from traditional resting and stress ECG techniques — Where medicine has historically taken a reductionistic view of the ECG, Premier Heart’s MCG™ technology uses an integrative approach, building a mathematical model of the entire cardiac system. This approach allows MCG™ to obtain accurate diagnoses from a simple, non-invasive test.
Premier Heart’s system consists of three stages:
- First, the medical provider collects resting ECG data from the patient.
This process is similar to a standard resting ECG and can be performed quickly and easily in nearly any setting. The ECG data is transmitted to Premier Heart’s data center via an encrypted internet connection.
- Once received at Premier Heart’s data center
The MCG™ diagnostic system takes over, running a series of mathematical transformations on the raw ECG data to identify distinct functional indices. These indices are compared to our clinically validated database and a numeric MCG™ Score is assigned to represent the severity of cardiac disease burden observed during the test. In addition to the MCG™ Score, the system also provides a set of differential diagnoses for specific conditions contributing to the result, giving the treating physician guidelines for additional evaluation and treatment.
- The MCG™ Score and identified conditions are compiled
Into an easy-to-read report which the physician can review on the MCG™ unit, or any computer with a web browser. These reports can provide guidance when developing a treatment plan or in referring a patient to a cardiologist for follow-up testing. Sample reports for normal and abnormal patients are available.
Want to know more?
Spotlight on New MCG™
Laurie Kaplan, RDN, LD
Hearts Warrior
PO Box 365
Dunlap, IL 61525
HeartsWarrior8@gmail.com
(309) 303-4450